CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
Given that hepsin / mice were reported to have elevated mRNA levels of mitochondrial Cpt1b , Cpt2 , and Cox7a1 in adipose tissues compared with wild-type mice, suggesting a regulatory role for hepsin in metabolism (Li et al
University of Michigan Health.
Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, et al
peptide therapy The Youth Hormone Boosters What they do: Increase growth hormone levels naturally for muscle repair, fat loss, and better sleep Why kids have it better: They naturally produce more growth hormone, leading to faster recovery and better overall health
